Arşiv logosu
  • Türkçe
  • English
  • Giriş
    Yeni kullanıcı mısınız? Kayıt için tıklayın. Şifrenizi mi unuttunuz?
Arşiv logosu
  • Koleksiyonlar
  • Sistem İçeriği
  • Analiz
  • Talep/Soru
  • Türkçe
  • English
  • Giriş
    Yeni kullanıcı mısınız? Kayıt için tıklayın. Şifrenizi mi unuttunuz?
  1. Ana Sayfa
  2. Yazara Göre Listele

Yazar "Dunyamaliyev, Orkhan Galib" seçeneğine göre listele

Listeleniyor 1 - 1 / 1
Sayfa Başına Sonuç
Sıralama seçenekleri
  • Yükleniyor...
    Küçük Resim
    Öğe
    Comparison of Tumor Regression Rate in Cervical Cancer Patients Treated with Radiotherapy Alone versus Chemoradiotherapy
    (Düzce Üniversitesi, 2010) Akbarov, Kamal Sabir; Asgarov, Niyazi Mustafa; Guliyev, Elchin Huseyn; Kazimov, Kamal İdrak; Dunyamaliyev, Orkhan Galib; Akbarov, Kamal S
    Aim: The aim of the research was to compare the tumor regression rate between Cervical Cancer patients treated with radiation therapy alone or concurrent chemo-radiotherapy. Patients and methods: Seventy-two patients with IIA-IIIB stage cervical cancer were included. Patients were divided to 2 groups. In group I, we used EBRT in total dose of 46-50 Gy and HDR ICBT – two divided doses of 9,0 Gy weekly. In group II, we carried out the same radiotherapy regimen with additionally cisplatin (40 mg/m2, weekly, 5 weeks). The longest diameter of the tumor before treatment was compared to measurement after EBRT but prior to ICBT. Treatment response rate was evaluated 1 month after end of the treatment. Results: Tumor regression prior to ICBT varied widely, ranging from 12% to 61%. However, the tumor regression rate was higher in patients treated with chemo-radiotherapy, ranging from 39% to 61% (Mean 53%) compared to radiotherapy alone ranging from 12% to 49% (Mean 35%). In tumors with longest diameter ?5 cm, tumor regression rate was ranged between 12% to 42% (median 26,2%) in patients treated with radiotherapy alone, and between 39% to 48% (median 44,8%) in patients treated with chemoradiotherapy. Conclusions: Outcome of this study for advanced cervical cancer treated by EBRT, brachytherapy and simultaneous chemotherapy shows satisfactory tumor shrinkage rate among all patients. Our results show that tumor regression rate is significantly higher in patients treated with concurrent chemoradiotherapy compared to radiotherapy alone.

| Düzce Üniversitesi | Kütüphane | Açık Erişim Politikası | Rehber | OAI-PMH |

Bu site Creative Commons Alıntı-Gayri Ticari-Türetilemez 4.0 Uluslararası Lisansı ile korunmaktadır.


Düzce Üniversitesi, Kütüphane ve Dokümantasyon Daire Başkanlığı, Düzce, TÜRKİYE
İçerikte herhangi bir hata görürseniz lütfen bize bildirin

DSpace 7.6.1, Powered by İdeal DSpace

DSpace yazılımı telif hakkı © 2002-2025 LYRASIS

  • Çerez Ayarları
  • Gizlilik Politikası
  • Son Kullanıcı Sözleşmesi
  • Geri Bildirim